---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-035624"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2025-11-18T23:59:59+00:00"
generated_at: "2026-05-16T18:48:19.843128+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics sets Dec 30, 2025 annual meeting; Nov 28 deadline for proposals

## Summary
- Annual meeting scheduled for December 30, 2025; proxy statement to be filed with SEC.
- Shareholder proposals for proxy inclusion under Rule 14a-8 must be received by November 28, 2025.
- Director nominations and other non-14a-8 proposals also due by November 28, 2025.
- All proposals must be submitted in writing to Corporate Secretary at Bay Harbor Islands address.

## SEC filing metadata
- accession: 0001437749-25-035624
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2025-11-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- confidence: high
- sec_items: 5.08, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/0001437749-25-035624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/atxi20251118c_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-035624
- JSON: https://secwatch.observer/filing/0001437749-25-035624.json
- Plain text: https://secwatch.observer/filing/0001437749-25-035624.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.